Corpus Intelligence IC Memo — MEDICAL CITY FORT WORTH 2026-04-26 08:02 UTC
IC Memo — MEDICAL CITY FORT WORTH
Investment Committee Memorandum | TX | 209 beds | Grade C | EBITDA uplift $27.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MEDICAL CITY FORT WORTH

CCN 450672 | TARRANT, TX | 209 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MEDICAL CITY FORT WORTH is a 209-bed suburban community hospital in TARRANT, TX with $375.9M in net patient revenue and a 22.9% operating margin. The hospital serves a payer mix of 24.9% Medicare, 0.6% Medicaid, and 74.5% commercial.

Thesis: Platform Growth. Our ML models identify $27.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 22.9% to 30.3% (+736bps).

Net Revenue HCRIS$375.9M
Current EBITDA COMPUTED$86.1M
Operating Margin COMPUTED22.9%
Occupancy HCRIS77.0%
Revenue / Bed COMPUTED$1.8M
Net-to-Gross HCRIS11.2%
Distress Probability ML38.5%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
148
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 22.9% places it above the state median. Among 148 size-comparable peers (104-418 beds), the median margin is 4.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (104-418), prioritizing same-state peers. 148 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MEDICAL CITY FORT WORTH (Target)TX209$375.9M22.9%
CHILDRENS MEDICAL CENTER OF DATX377$1.56B10.3%
DELL CHILDRENS MEDICAL CENTERTX262$901.9M25.5%
DOCTORS HOSPITAL AT RENAISSANCTX394$847.8M9.2%
ASCENSION SETON MEDICAL CENTERTX391$702.5M12.6%
DRISCOLL CHILDRENS HOSPITALTX215$694.3M29.4%
ROUND ROCK HOSPITALTX165$681.4M8.7%
METHODIST SUGAR LAND HOSPITALTX337$679.6M12.6%
METHODIST WILLOWBROOK HOSPITALTX346$661.8M10.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $27.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$7.9M+210bp18mo
Cost to Collect4.5%2.5%$7.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$7.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.6M+122bp9mo
Clean Claim Rate88.0%96.0%$241K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$7.9M
Cost to Collect
$7.5M
Denial Rate Reduction
$7.4M
A/R Days Reduction
$4.6M
Clean Claim Rate
$241K
Total EBITDA Uplift$27.7M
Current EBITDA$86.1M
+ RCM Uplift+$27.7M
Pro Forma EBITDA$113.8M
Current Margin22.9%
Pro Forma Margin30.3%
WC Released (1x)$14.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$132.5M$844.8M6.38x44.9%
Base (11x exit)10.0x11.0x$132.5M$972.3M7.34x49.0%
Bull Case9.0x11.0x$119.2M$1.11B9.28x56.1%
Bull (12x exit)9.0x12.0x$119.2M$1.24B10.42x59.8%
Bear Case11.0x10.0x$145.7M$663.4M4.55x35.4%
Bear (11x exit)11.0x11.0x$145.7M$777.1M5.33x39.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 148 hospitals with 104-418 beds
  • Same-state prioritization (n=149)
  • Comp margins: P25=-6.7% / P50=4.9% / P75=13.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.